SCHEMBL17845912

SCHEMBL17845912

Cc1c(CCl)ccc(I)c1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17068415 0.71 NOTUM (0.39) NOTUM
SCHEMBL1019627 0.70 PON1 (0.35)
SCHEMBL11397537 0.68 NOTUM (0.50) NOTUM
SCHEMBL24573784 0.67 NOTUM (0.43) NOTUM
SCHEMBL18721394 0.66 NOTUM (0.42) NOTUM
SCHEMBL21768201 0.66 TAAR1 (0.35)
SCHEMBL30831841 0.66 TAAR1 (0.35)
SCHEMBL24622550 0.66 NOTUM (0.42) NOTUM
SCHEMBL17845893 0.65 P2RX7 (0.42) NOTUM
SCHEMBL28035154 0.65 IDO1 (0.40) NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233862-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS 3 INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2017-10-25 EP disclosed
WO-2016097347-A1 IMIDAZOPYRIDAZINE DERIVATIVES AS ΡΙ3Κβ INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2016-06-23 WO disclosed